Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Antengene Corporation Limited ( (HK:6996) ) has shared an announcement.
Antengene Corporation Limited has established a Nomination and Corporate Governance Committee as part of its corporate governance framework. This committee, formed by a board resolution on August 18, 2020, is tasked with overseeing the nomination process for directors and ensuring adherence to corporate governance standards, which could enhance the company’s operational efficiency and stakeholder trust.
The most recent analyst rating on (HK:6996) stock is a Hold with a HK$4.00 price target. To see the full list of analyst forecasts on Antengene Corporation Limited stock, see the HK:6996 Stock Forecast page.
More about Antengene Corporation Limited
Antengene Corporation Limited is a biopharmaceutical company that focuses on the development and commercialization of innovative oncology therapies. The company is committed to addressing unmet medical needs and improving the lives of cancer patients across the Asia-Pacific region and globally.
Average Trading Volume: 2,852,269
Technical Sentiment Signal: Hold
Current Market Cap: HK$2.83B
Learn more about 6996 stock on TipRanks’ Stock Analysis page.